| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO
1 company
William J Welch last filed a Form 4 in January 2018, as Chief Executive Officer at CRDF. William J Welch's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 842,645 shares of CRDF. Net of sales, the CRDF filings show accumulation of 4,750 shares.
William J Welch has 7 Form 4 filings on record from December 2016 to January 2018, all as Chief Executive Officer at Cardiff Oncology (CRDF), 2016–2018.
The 10 reported transactions were 3 option or other derivative awards, 2 option exercises, 2 tax withholdings and 2 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $10K and no sales.
The only open-market purchase was 4,750 shares of CRDF at an average $2.09 on December 16, 2016, about $10K.
Shares as reported in the last Form 4 for each company; the most recent is from January 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2016 | CRDF Cardiff Oncology, Inc. | CEO | Buy | 4,750 | $2.09 | $9,943.50 | New |